4-54263664-C-T

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_006206.6(PDGFRA):​c.368-3C>T variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0629 in 1,612,354 control chromosomes in the GnomAD database, including 3,637 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.046 ( 226 hom., cov: 32)
Exomes 𝑓: 0.065 ( 3411 hom. )

Consequence

PDGFRA
NM_006206.6 splice_region, intron

Scores

2
Splicing: ADA: 0.02828
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: 2.39
Variant links:
Genes affected
PDGFRA (HGNC:8803): (platelet derived growth factor receptor alpha) This gene encodes a cell surface tyrosine kinase receptor for members of the platelet-derived growth factor family. These growth factors are mitogens for cells of mesenchymal origin. The identity of the growth factor bound to a receptor monomer determines whether the functional receptor is a homodimer or a heterodimer, composed of both platelet-derived growth factor receptor alpha and beta polypeptides. Studies suggest that this gene plays a role in organ development, wound healing, and tumor progression. Mutations in this gene have been associated with idiopathic hypereosinophilic syndrome, somatic and familial gastrointestinal stromal tumors, and a variety of other cancers. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.21).
BP6
Variant 4-54263664-C-T is Benign according to our data. Variant chr4-54263664-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 259954.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr4-54263664-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0692 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PDGFRANM_006206.6 linkuse as main transcriptc.368-3C>T splice_region_variant, intron_variant ENST00000257290.10 NP_006197.1 P16234-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PDGFRAENST00000257290.10 linkuse as main transcriptc.368-3C>T splice_region_variant, intron_variant 1 NM_006206.6 ENSP00000257290.5 P16234-1
ENSG00000282278ENST00000507166.5 linkuse as main transcriptc.1018-11261C>T intron_variant 2 ENSP00000423325.1 A0A0B4J203

Frequencies

GnomAD3 genomes
AF:
0.0461
AC:
7019
AN:
152126
Hom.:
226
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0118
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0423
Gnomad ASJ
AF:
0.0332
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.0406
Gnomad FIN
AF:
0.0607
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.0709
Gnomad OTH
AF:
0.0436
GnomAD3 exomes
AF:
0.0488
AC:
12265
AN:
251276
Hom.:
405
AF XY:
0.0504
AC XY:
6844
AN XY:
135806
show subpopulations
Gnomad AFR exome
AF:
0.0102
Gnomad AMR exome
AF:
0.0246
Gnomad ASJ exome
AF:
0.0348
Gnomad EAS exome
AF:
0.000381
Gnomad SAS exome
AF:
0.0478
Gnomad FIN exome
AF:
0.0628
Gnomad NFE exome
AF:
0.0684
Gnomad OTH exome
AF:
0.0489
GnomAD4 exome
AF:
0.0646
AC:
94328
AN:
1460110
Hom.:
3411
Cov.:
32
AF XY:
0.0644
AC XY:
46750
AN XY:
726448
show subpopulations
Gnomad4 AFR exome
AF:
0.00938
Gnomad4 AMR exome
AF:
0.0270
Gnomad4 ASJ exome
AF:
0.0347
Gnomad4 EAS exome
AF:
0.000353
Gnomad4 SAS exome
AF:
0.0490
Gnomad4 FIN exome
AF:
0.0653
Gnomad4 NFE exome
AF:
0.0726
Gnomad4 OTH exome
AF:
0.0556
GnomAD4 genome
AF:
0.0461
AC:
7015
AN:
152244
Hom.:
226
Cov.:
32
AF XY:
0.0455
AC XY:
3388
AN XY:
74440
show subpopulations
Gnomad4 AFR
AF:
0.0118
Gnomad4 AMR
AF:
0.0422
Gnomad4 ASJ
AF:
0.0332
Gnomad4 EAS
AF:
0.000579
Gnomad4 SAS
AF:
0.0406
Gnomad4 FIN
AF:
0.0607
Gnomad4 NFE
AF:
0.0709
Gnomad4 OTH
AF:
0.0427
Alfa
AF:
0.0587
Hom.:
168
Bravo
AF:
0.0409
Asia WGS
AF:
0.0190
AC:
67
AN:
3478
EpiCase
AF:
0.0649
EpiControl
AF:
0.0636

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxJun 22, 2018This variant is associated with the following publications: (PMID: 27884173, 20169295) -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesNov 29, 2023- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Gastrointestinal stromal tumor Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Hereditary cancer-predisposing syndrome Benign:2
Benign, criteria provided, single submittercurationSema4, Sema4Feb 06, 2020- -
Benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 13, 2018This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Idiopathic hypereosinophilic syndrome Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.21
CADD
Benign
12
DANN
Benign
0.93

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.028
dbscSNV1_RF
Benign
0.046
SpliceAI score (max)
0.070
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs55947416; hg19: chr4-55129831; COSMIC: COSV57265057; COSMIC: COSV57265057; API